Facebook
Twitter
Telegram
Report an ErrorCerevel Therapeutics Holdings Financial Statements 2011-2024 | CERE
Annual Financial Statements Cerevel Therapeutics Holdings
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
6.68 B | 4 B | 4.43 B | 1.22 B | - | - | - | - | - | - | - | - | - |
Shares |
162 M | 151 M | 137 M | 73.6 M | - | - | - | - | - | - | - | - | - |
Historical Prices |
41.2 | 26.4 | 32.4 | 16.6 | - | - | - | - | - | - | - | - | - |
Net Income |
-433 M | -352 M | -225 M | -152 M | - | - | - | - | -28.2 M | -29.3 M | -32.5 M | -29.4 M | - |
Revenue |
- | - | - | - | - | - | - | - | 2.72 M | 2.4 M | 5.24 M | 5.37 M | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | -2.55 M | -617 K | -1 M | 2.99 M | - |
Operating Income |
-447 M | -368 M | -220 M | -149 M | -83.5 M | - | - | - | - | - | - | - | - |
Interest Expense |
10.6 M | 3.92 M | -5.39 M | -3.27 M | -46.4 M | - | - | - | - | - | - | - | - |
EBITDA |
-442 M | -363 M | -217 M | -149 M | - | - | - | - | -27.5 M | -27.7 M | -30.7 M | -26.7 M | - |
Operating Expenses |
447 M | 368 M | 220 M | 149 M | - | - | - | - | 30.9 M | 31.7 M | 37.8 M | 31.8 M | - |
General and Administrative Expenses |
113 M | 87.6 M | 58.2 M | 45.8 M | - | - | - | - | 15.9 M | 14.5 M | 15.2 M | 12.6 M | - |
All numbers in USD currency
Quarterly Income Statement Cerevel Therapeutics Holdings
| 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
182 M | 181 M | 157 M | 157 M | 157 M | 157 M | 152 M | 148 M | 148 M | 148 M | 144 M | 127 M | 127 M | 127 M | 63.3 M | 60.9 M | 60.9 M | 60.9 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income |
-132 M | - | -96.4 M | -99.5 M | -104 M | - | -99.9 M | -90.5 M | -68.3 M | - | -62.1 M | -53.2 M | -51 M | - | -39 M | -26.7 M | -53.2 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-143 M | - | -111 M | -96.8 M | -99.6 M | - | -95.1 M | -93 M | -72.5 M | - | -54.5 M | -50.5 M | -50.6 M | - | -34.4 M | -35.2 M | -37.7 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
2.65 M | - | 2.64 M | 2.64 M | 2.64 M | - | 1.29 M | 1.87 M | 3.94 M | - | -7.54 M | -2.74 M | -425 K | - | -4.68 M | 8.42 M | -15.7 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
-141 M | - | - | - | -98.2 M | - | -91.5 M | -93 M | -71.4 M | - | -52.9 M | -50.5 M | -50.5 M | - | -34 M | -34.9 M | -37.6 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses |
143 M | - | 111 M | 96.8 M | 99.6 M | - | 95.1 M | 93 M | 72.5 M | - | 54.5 M | 50.5 M | 50.6 M | - | 34.4 M | 35.2 M | 37.7 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
36.2 M | - | 26.1 M | 22.8 M | 21.4 M | - | 23.7 M | 20.5 M | 17.5 M | - | 14.4 M | 13.2 M | 14 M | - | 10.3 M | 13 M | 10.7 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency